ESC Premium Access

Edoxaban and implantable cardiac device interventions - Insights from the ENGAGE AF-TIMI 48 trial

Congress Presentation

About the speaker

Professor Jan Steffel

Swiss EP AG, Zurich (Switzerland)
77 presentations
23 followers

10 more presentations in this session

Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Thumbnail

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

Speaker: Doctor G. Simonyi (Budapest, HU)

Thumbnail

Prior antithrombotic therapy: a snapshot of 17,769 patients from the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF)

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Oral anticoagulation continuation vs. discontinuation after catheter-ablation of paroxysmal atrial fibrillation - incidence of cerebral insults and severe hemorrhagic complications

Speaker: Ms L. Pracht (Munich, DE)

Thumbnail

A new score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 2

Speakers: Professor J. Steffel, Associate Professor B. Hudzik, Doctor G. Simonyi, Professor R. De Caterina, Ms L. Pracht...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb